Understanding the dynamics of hepatitis C virus transmission in a high-risk environment

N Bretana - 2017 - unsworks.unsw.edu.au
HCV is mainly transmitted between people who inject drugs in developed countries. In this
population, HCV prevalence is high and incarceration is recognised to be an independent …

[PDF][PDF] Transmission and treatment of hepatitis C virus infection in people who inject drugs

E Cunningham - 2017 - unsworks.unsw.edu.au
Aims: The broad aim of this research was to inform prevention and treatment of HCV
infection in PWID. Specific aims included the evaluation of injecting risk behaviours and …

[图书][B] Optimal Information Collection for Dynamic Health Care Policy

LE Cipriano - 2013 - search.proquest.com
Mathematical models of health systems and disease can provide important information to
decision makers when direct experimentation is impossible, impractical, or unethical, and …

[PDF][PDF] Modelling HIV and hepatitis C among injecting drug users in Australia and HIV among risk groups in Indonesia: projection and cost-effectiveness analysis

JA Kwon - 2012 - unsworks.unsw.edu.au
Sharing syringes by people who inject drugs (PWID) is an important mode of global
transmission of blood borne viruses such as HIV and hepatitis C virus (HCV)[102]. Both HIV …

[PDF][PDF] p. 405 Investigations croisées autour de cas de tuberculose en lycée, Seine-Saint-Denis, France, 2009-2010

A Ceyriac, S Boiron - ristretti.it
Résumé/Abstract Introduction–En France, la prévention du risque infectieux en prison est
encadrée par deux textes émanant conjointement des ministères en charge de la Justice et …

[PDF][PDF] THE CASE FOR PRISON SYRINGE EXCHANGE: 10 reasons why sterile syringes should be provided to prisoners

J Nelles - iprt.ie
This brief is excerpted from the report, Prison Needle Exchange: A Review of International
Evidence and Experience (R Lines, R Jürgens, H Stöver, D Laticevschi, J Nelles) to be …

[PDF][PDF] Identification and optimisation of evidence-based HCV prevention in Europe for young drug users at risk

H Zurhold, C Schmidt - 2011 - aidsactioneurope.org
Hepatitis C is a major global health problem. Requiring widespread interventions for its
prevention and control, it has been considered one of the major challenges in the third …

Reply to Gyarmathy

H Hagan, ER Pouget, RS Garfein - The Journal of Infectious …, 2010 - academic.oup.com
To the Editor—In her letter, Gyarmathy [1] suggested that our analysis of hepatitis C virus
(HCV) seroconversion in injection drug users [2] may have failed to detect an association …

[PDF][PDF] Best Practices and Interventions for the Diagnosis and Treatment of Hepatitis C

A Part, B Part - Journal of Hepatology, 2009 - cagh-acsm.org
Background: Telaprevir is a hepatitis C NS3/4A protease inhibitor approved by the US Food
and Drug Administration as part of combination therapy for the management of chronic …

Каковы фактические данные об эффективности мер по снижению распространенности гепатита С и связанной с ним заболеваемости?

NMJ Wright, CE Millson… - … об эффективности мер …, 2005 - pesquisa.bvsalud.org
ABSTRACT Вашему вниманию предлагается синтезированный доклад Сети
фактических данных по вопросам здоровья (HEN) об эффективных вмешательствах с …